Score Breakdown
Dilution Forecast
Market Data
Source-Backed Evidence Depth
This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.
| Field | Current Value | Basis |
|---|---|---|
| DilutionScore | 79/100 | DilutionWatch score record |
| Shares Outstanding | 43.50M | Verified float table or market cache |
| Public Float | 14.11M | Verified float table or market cache |
| Market Cap | $14.31M | Market data cache |
| Cash Runway | 0.1 months | DilutionWatch score inputs |
| Shelf Capacity | None in current score inputs | SEC-derived dilution fields |
| ATM Capacity | None in current score inputs | SEC-derived dilution fields |
| Outstanding Warrants | 2.21M | SEC-derived dilution fields |
Recent source-backed SEC insight records available on this page: 2.
Recent SEC source mix: XBRL 2.
The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.
Institutional Holdings
Short Interest
Recent SEC Activity
Recent News
Factual ESLA Dilution Snapshot
Estrella Immunopharma, Inc. (ESLA) has a DilutionScore of 79/100, rated Critical dilution risk. Score date: October 13, 2026.
- Stored outstanding warrants: 2.2M.
- Recent SEC activity tracked for ESLA: xbrl on 2026-08-13; xbrl on 2023-08-01.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
DilutionScore History — Last 90 Days
ESLA's DilutionScore is currently 79/100 (Critical risk), with 1 score change tracked over 89 days. The score deteriorated from 84/100 (Critical risk).
| Period | Score | Risk Level | Duration |
|---|---|---|---|
| Sep 28 – Oct 13, 2026 | 79/100 | CRITICAL | 16 days |
| Jul 16 – Sep 27, 2026 | 84/100 | CRITICAL | 73 days |
Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.
Share Dilution History
ESLA shares outstanding have increased 2.4% from 42.03M (Mar 2026) to 43.03M (May 2026). Each increase represents potential dilution to existing shareholders.
| Date | Shares Outstanding | Public Float | Change |
|---|---|---|---|
| May 26, 2026 | 43.03M | 14.11M | ▲ 1.80% |
| May 25, 2026 | 43.03M | 13.86M | ▼ 1.30% |
| May 20, 2026 | 43.03M | 14.04M | ▲ 0.86% |
| May 18, 2026 | 42.67M | 13.92M | ▼ 22.74% |
| Mar 26, 2026 | 42.67M | 18.02M | ▲ 2.10% |
| Mar 19, 2026 | 42.03M | 17.65M | ▲ 12.97% |
Share counts sourced from verified regulatory filings. Increases indicate dilution events.
Related Stocks — CRITICAL Risk
Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.